Studies in other cancers have shown that the use of IFN-α, a ligand that activates IFNAR1, can promote stem-like properties in oral squamous cell carcinoma (OSCC) cells, whereby tumor xenografts treated with IFN-α increased the expression of stemness markers and tumor growth [53,54]. Here, IFNAR1 is linked to neoplasm.